Literature DB >> 25550532

The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.

Robert Fuchs1, Gert Schwach1, Anika Stracke1, Nathalie Meier-Allard1, Markus Absenger2, Elisabeth Ingolic3, Helga Susanne Haas1, Roswitha Pfragner1, Anton Sadjak1.   

Abstract

BACKGROUND/AIM: Medullary thyroid carcinoma (MTC) is a tumor associated with poor prognosis since it exhibits high resistance against conventional cancer therapy. Recent studies have shown that quinazolines exhibit a pro-apoptotic effect on malignant cells. The aim of the present study was to elucidate whether MTC cells are affected by quinazolines, in particular prazosin.
MATERIALS AND METHODS: Proliferation, apoptosis and cell morphology of the MTC cell line TT were analyzed by WST-1 assay, caspase 3/7 activation tests and microscopy. Fibroblasts were used as control for non-malignant cells.
RESULTS: Prazosin potently inhibited the growth of TT cells, induced apoptosis and caused vacuolization, as well as needle-like filopodia. Fibroblasts were affected by prazosin in the same way as MTC cells.
CONCLUSION: MTC cells are responsive to prazosin treatment similar to other malignancies. The fact that fibroblasts also respond to prazosin further highlights the importance to identify the unknown pro-apoptotic target of quinazolines. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Medullary thyroid carcinoma; apoptosis; cell culture; prazosin; quinazolines; α1-adrenergic receptors

Mesh:

Substances:

Year:  2015        PMID: 25550532      PMCID: PMC4290659     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  35 in total

1.  Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?

Authors:  Emad J Siddiqui; Majid Shabbir; Cecil S Thompson; Faiz H Mumtaz; Dimitri P Mikhailidis
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

2.  Effects of alprostadil and prazosin on motility, viability and membrane integrity of human sperm.

Authors:  W J Hellstrom; R Wang; C A Peterson; J C Varady; N Gesundheit; S C Sikka
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

3.  Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-I).

Authors:  R Pfragner; G Wirnsberger; B Niederle; A Behmel; I Rinner; A Mandl; F Wawrina; J Luo; D Adamiker; H Hoger; E Ingolic; K Schauenstein
Journal:  Int J Oncol       Date:  1996-03       Impact factor: 5.650

Review 4.  Role of mitochondrial Ca2+ in the regulation of cellular energetics.

Authors:  Brian Glancy; Robert S Balaban
Journal:  Biochemistry       Date:  2012-03-29       Impact factor: 3.162

5.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.

Authors:  M Caine; S Perlberg; S Meretyk
Journal:  Br J Urol       Date:  1978-12

Review 6.  Molecular genetics of multiple endocrine neoplasia types 1 and 2.

Authors:  Stephen J Marx
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

7.  Christia vespertilionis plant extracts as novel antiproliferative agent against human neuroendocrine tumor cells.

Authors:  Daniela Hofer; Gert Schwach; Nassim Ghaffari Tabrizi-Wizsy; Anton Sadjak; Sonja Sturm; Hermann Stuppner; Roswitha Pfragner
Journal:  Oncol Rep       Date:  2013-03-26       Impact factor: 3.906

8.  Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.

Authors:  Manory A Fernando; Anthony P Heaney
Journal:  Mol Endocrinol       Date:  2005-07-14

9.  Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.

Authors:  Eriko Masachika; Takeshi Kanno; Takashi Nakano; Akinobu Gotoh; Tomoyuki Nishizaki
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

10.  Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent.

Authors:  Venkatramana M Rao; Erika A Zannou; Valentino J Stella
Journal:  J Pharm Sci       Date:  2010-12-01       Impact factor: 3.534

View more
  7 in total

1.  Adrenoceptor modulators and cancer progression.

Authors:  Kazuyoshi Hirota
Journal:  J Anesth       Date:  2016-04-06       Impact factor: 2.078

2.  Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc.

Authors:  Robert Fuchs; Anika Stracke; Viktoria Holzmann; Gerfried Luschin-Ebengreuth; Nathalie Meier-Allard; Nadine Ebner; Teresa Maria Lassacher; Markus Absenger-Novak; Eleonore Fröhlich; Matthias Schittmayer; Sara Cano Crespo; Manuel Palacin; Beate Rinner; Ruth Birner-Gruenberger
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-06-15       Impact factor: 4.739

Review 3.  The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers.

Authors:  Mallory Batty; Rachel Pugh; Ilampirai Rathinam; Joshua Simmonds; Edwin Walker; Amanda Forbes; Shailendra Anoopkumar-Dukie; Catherine M McDermott; Briohny Spencer; David Christie; Russ Chess-Williams
Journal:  Int J Mol Sci       Date:  2016-08-16       Impact factor: 5.923

4.  Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.

Authors:  Jianfeng Ma; Jinchun Qi; Shoubin Li; Chaohua Zhang; Haijiang Wang; Lijun Shao; Xiaofei Yuan; Quan Sha
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  Pizotifen inhibits the proliferation and invasion of gastric cancer cells.

Authors:  Ying Jiang; Wei Wang; Xi Wu; Jihua Shi
Journal:  Exp Ther Med       Date:  2019-12-09       Impact factor: 2.447

6.  The cytotoxicity of the α1-adrenoceptor antagonist prazosin is linked to an endocytotic mechanism equivalent to transport-P.

Authors:  Robert Fuchs; Anika Stracke; Nadine Ebner; Christian Wolfgang Zeller; Anna Maria Raninger; Matthias Schittmayer; Tatjana Kueznik; Markus Absenger-Novak; Ruth Birner-Gruenberger
Journal:  Toxicology       Date:  2015-10-09       Impact factor: 4.221

7.  Prazosin inhibits the growth and mobility of osteosarcoma cells.

Authors:  Ming An; Wen-Hai Ma; Hong-Wei Jia; Yong-Wang Li; Jing-Jing Feng; Jing Meng; Hui Qi; Jin Liu
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.